Bioprosthetic tricuspid valve stenosis: a case series
Open Access
- 13 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (3)
Abstract
Background: Bioprosthetic tricuspid valve stenosis is a late sequela of tricuspid valve replacement (TVR); however, detailed information regarding its clinical picture is lacking. Case summary: Thirty-one patients with bioprosthetic TVR (mean age: 60.5 ± 16.6 years, male/female: 11/20) were followed-up for 79.5 ± 49.1 months (14–188 months). Eleven patients developed bioprosthetic tricuspid valve stenosis (mean tricuspid gradient >5 mmHg) at a median interval of 96 months (interquartile range: 61–114 months). The mean tricuspid gradient at the time of tricuspid valve stenosis diagnosis was 10.9 ± 3.9 mmHg. Although the mid-term tricuspid valve stenosis-free survival was favourable (92.4% at 60 and 78.7% at 84 months), it had declined steeply to 31.5% by 120 months. Ten out of 11 tricuspid valve stenosis patients showed signs of right heart failure (RHF) as manifested by oedema and elevated jugular venous pressure, requiring moderate-to-high doses of diuretics. Diastolic rumble was audible in 10 patients. Five of the 11 tricuspid valve stenosis patients required redo TVR as a result of refractory RHF. Examination of the five excised bioprostheses showed pannus in four, fusion of the commissure in three, native valve attachment in two, and sclerosis in one. Detailed clinical pictures and pathology of the explanted valves in three cases that underwent surgery are presented in this case series. Discussion: Bioprosthetic tricuspid valve stenosis is not uncommon after 8 years. Tricuspid valve replacement performed at the second surgery was associated with a higher incidence of bioprosthetic tricuspid valve stenosis.Keywords
This publication has 11 references indexed in Scilit:
- Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current PerspectiveThe Annals of Thoracic Surgery, 2016
- Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantationsThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Long-term results of bioprosthetic tricuspid valve replacement: an analysis of 25 years of experienceGeneral Thoracic and Cardiovascular Surgery, 2012
- Outcomes of Tricuspid Valve Repair and Replacement: A Propensity AnalysisThe Annals of Thoracic Surgery, 2009
- Percutaneous Transcatheter Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve StenosisCirculation, 2006
- Long-Term Outcomes of Tricuspid Valve Replacement in the Current EraThe Annals of Thoracic Surgery, 2005
- Biological or mechanical prostheses in tricuspid position? a meta-analysis of intra-institutional resultsThe Annals of Thoracic Surgery, 2004
- Tricuspid valve replacement: an analysis of 25 years of experience at a single centerThe Annals of Thoracic Surgery, 2003
- Tricuspid valve replacement with bioprostheses: long-term results and causes of valve dysfunctionThe Annals of Thoracic Surgery, 2001
- Ten-year experience with the Carpentier-Edwards pericardial xenograft in the tricuspid positionThe Journal of Thoracic and Cardiovascular Surgery, 1996